Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery

氯诺昔康 透皮 渗透 壳聚糖 药品 药物输送 溶解度 材料科学 色谱法 赋形剂 化学 药理学 纳米技术 有机化学 医学 膜 止痛药 生物化学
作者
Rahman Khan,Shefaat Ullah Shah,Sheikh Abdur Rashid,Faiza Naseem,Kifayat Ullah Shah,Arshad Farid,Khalid Rehman Hakeem,Majid Rasool Kamli,Eman Hillal Althubaiti,Soha A. Alamoudi
出处
期刊:Polymers [Multidisciplinary Digital Publishing Institute]
卷期号:14 (9): 1922-1922 被引量:42
标识
DOI:10.3390/polym14091922
摘要

Nanoemulsions are promising drug delivery systems for the administration of poorly soluble drugs like lornoxicam (LRX) by oral or parenteral routes. Such formulations work perfectly for transdermal delivery of lornoxicam-type drugs. It has also been established that formulating such a delivery system is highly dependent on the presence, type, and concentration of excipients taking part in the formulation. The inherent characteristics of nanoemulsion (NE), i.e., smaller globule size and excipient nature, facilitate the drug's passage through skin. The current study was aimed at the development of an NE-based formulation of LRX to improve the drug solubility in vitro as well as to enhance drug skin permeation to promote therapeutic outcome in appropriate time. Spontaneous self-emulsification technique was utilized to develop optimized LRX-encapsulated NE-based formulations. ATR-FTIR spectra of the pure drug and various formulations did not show any interaction between the drug and various formulation excipients showing compatibility. Globule size for stable formulations ranged between 63-168 nm. These formulations were characterized for viscosity, surface tension, pH, drug encapsulation efficiency, in vitro drug release, and drug skin permeation studies. Chitosan-decorated optimized NE formulation of LRX showed about 58.82% cumulative drug release, showing an anomalous non-Fickian diffusion mechanism of drug release. Drug encapsulation efficiency, in vitro drug release, and skin permeation studies exhibited promising results. An appreciable drug entrapment efficiency was exhibited by optimized NE formulations LRX-6, 71.91 ± 3.17% and C-LRX, 65.25 ± 4.89%. Permeability parameters like enhancement ratio (Er), permeability constant (Kp), and steady state flux (Jss) showed higher values and exhibited good results based on formulation type. The selected promising formulation type "LRX-6" showed significantly different results as compared to other formulations (LRX-4, 5, and 7). The skin permeation property of the LRX-6 formulation was compared to similar chitosan-based formulations and was found to have better skin permeation results than chitosan-based formulations. This study clearly exhibited that an LRX-containing NE-based formulation can be formulated to form a stable drug delivery system. Such formulations are promising in terms of physicochemical characteristics, improved solubility, and high skin permeation potential.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ycc完成签到,获得积分10
1秒前
1秒前
1秒前
嘟嘟发布了新的文献求助10
1秒前
2秒前
bkagyin的应助被Xk采纳,获得10
2秒前
自信南霜完成签到 ,获得积分10
3秒前
酷波er的应助被李琦采纳,获得10
3秒前
zbw发布了新的文献求助10
3秒前
llllu发布了新的文献求助10
4秒前
hansang完成签到,获得积分20
4秒前
Jasper的应助被鲤鱼鑫磊采纳,获得10
4秒前
5秒前
小马甲的应助被Shellbeaze采纳,获得10
6秒前
6秒前
无极微光的应助被霁月采纳,获得20
7秒前
小角落完成签到 ,获得积分10
8秒前
8秒前
852的应助被林见鹿采纳,获得10
9秒前
青衫发布了新的文献求助30
9秒前
9秒前
WYT123完成签到,获得积分10
10秒前
Eclin完成签到,获得积分10
10秒前
王富贵完成签到,获得积分10
10秒前
11秒前
叶子完成签到,获得积分10
11秒前
Boubou发布了新的文献求助10
11秒前
11秒前
鲁焦完成签到 ,获得积分10
11秒前
小小完成签到 ,获得积分10
11秒前
6666发布了新的文献求助10
12秒前
hega完成签到,获得积分20
12秒前
12秒前
13秒前
揽万里星河入梦完成签到,获得积分10
13秒前
13秒前
13秒前
deng发布了新的文献求助10
14秒前
15秒前
Hwtttt完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187412
求助须知:如何正确求助?哪些是违规求助? 9575481
关于积分的说明 21841736
捐赠科研通 7785184
什么是DOI,文献DOI怎么找? 3434949
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481846